Affini-T Therapeutics Employee Directory
Biotechnology ResearchMassachusetts, United States11-50 Employees
Affini-T Therapeutics is a clinical-stage biotechnology company based in Watertown, Massachusetts, focused on precision immunotherapies for solid tumors, with an emphasis on targeting oncogenic driver mutations beginning with KRAS. The company pursues two TCR-based therapeutic approaches intended to harness T cell activity with high specificity against solid tumors. Its programs are underpinned by advanced engineering, synthetic biology, and gene editing to address the challenges of solid-tumor targeting. Covering the biotechnology research sector, Affini-T is a relatively small to mid-sized enterprise developing therapies for patients with solid tumors. In 2024, the company announced the first patient dosed in its KRAS G12V Phase 1 program and reported a trial-in-progress presentation at ASCO 2024.